Anke Baum
2PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Sep 09, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.Birgit Wilding, Lydia Woelflingseder, Anke Baum
|Feb 08, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.Eun Ji Lee, Seung Yeon Oh, You Won Lee
Pageof 1
Frequent Collaborators
2 joint publications
Lydia Woelflingseder
2 joint publications
Flavio Solca
1 joint publications
Eun Ji Lee
1 joint publications
Seung Yeon Oh
1 joint publications
You Won Lee
1 joint publications
Ju Young Kim
1 joint publications
Min-Je Kim
1 joint publications
Tae Ho Kim
1 joint publications
Jii Bum Lee
1 joint publications
Min Hee Hong
